Gruber-Moesenbacher, U; Eiter, H; Cerkl, P; Popper, H.
Would patients with primary pulmonary carcinomas 40 years and younger profit from small molecule tyrosine kinase inhibitors?
VIRCHOWS ARCHIV. 2009; 455: 356-357.-22 European Congress of Pathology; SEP 4-9, 2009; Florence.
[Poster]
Web of Science